High prevalence of type 2 diabetes and pre-diabetes in adult Zoroastrians in Yazd, Iran
A cross-sectional study
Keywords:
type 2 diabetes, ethnic group, prevalence, pre-diabetesAbstract
Background: The prevalence of type 2 diabetes mellitus (T2DM) varies among ethnic groups. We aimed to estimate the prevalence of diagnosed and undiagnosed diabetes mellitus, impaired fasting glucose (IFG), and impaired glucose tolerance (IGT) for the first time in an ethnic population, specifically Zoroastrian citizens in Yazd, Iran whose ages were 30 or older.
Methods: In a cross-sectional study, participants aged≥30 years were selected using systematic random sampling. An inventory, including socio-demographic data, was completed. Weight, height, body mass index (BMI), and blood pressure (BP) were measured using standard methods. Also, blood levels of glucose, triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL), urea, creatinine (Cr), and uric acid were measured. The latest criteria established by the American Diabetes Association (ADA) were used to diagnose DM.
Results: The mean age of the participants (n=403) was 56.9±12.8 years. The total prevalence of diabetes, including previously diagnosed and undiagnosed diabetes, IFG, and IGT was 26.1%, 18.6%, 7.5%, 34.7% and 25.8%, respectively. Participants with diabetes had higher fasting blood sugar (FBS) (P<0.001), oral glucose tolerance test (OGTT) (P<0.001), urea (P=0.019), BMI (P=0.001), systolic blood pressures (P<0.001), TG (P=0.007) and lower HDL (P=0.034) than patients with IFG, IGT, and normoglycemic subjects.
Conclusions: The current study showed a high prevalence of T2DM in the Zoroastrian population of Yazd, Iran. One-third of the total cases with diabetes were undiagnosed.
References
Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of Type 2 diabetes and its associated risk
factors: results from a six-year cohort study in Iran. BMC public health. 2009; 9:186.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and
projections for 2030. Diabetes care. 2004 May; 27(5):1047-53.
Afkhami-Ardekani M, Vahidi S, Vahidi A, Ahmadie MH. The prevalence of type 2 diabetes mellitus on age of
years and obove in Yazd province (Iranian population). Journal of Shahid Sadoughi University of Medical
Science and Health Services 2001; 9(1):22-27.
Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 2002,
:149-155.
Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, et al. Ethnicity, obesity, and risk of type 2
diabetes in women: a 20-year follow-up study. Diabetes care. 2006 Jul; 29(7):1585-90.
Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States.
Ann Intern Med 1996; 125:221.
Franse LV, Di Bari M, Shorr RI, Resnick HE, van Eijk JT, Bauer DC,Newman AB, Pahor M: Type 2 diabetes
in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition
study. Diabetes care 2001, 24(12):2065-2070.
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD:
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third
National Health and Nutrition Examination Survey, 1988-1994. Diabetes care 1998, 21(4):518-524.
Wilson PW, Cupples LA, Kannel WB: Is hyperglycemia associated with cardiovascular disease? The
Framingham Study. Am Heart J 1991, 121(2 Pt 1):586-590.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects
with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med
, 339(4):229-234.
Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the
current status on definition and intervention. Diabet Med 2002, 19(9):708-723.
Lawrence JM, Bennett P, Young A, Robinson AM: Screening for diabetes in general practice: cross sectional
population study. Bmj 2001, 323(7312):548-551.
Boyce M. A History of Zoroastrianism – The Early Period.London, Brill Academic Publications, 1996.
Farjadian S, Sazzini M, Tofanelli S, Castri L, Taglioli L, Pettener D, Ghaderi A, et al. Discordant patterns of
mtDNA and ethno-linguistic variation in 14 Iranian Ethnic groups. Human heredity 2011; 72:73-84
Diagnosis and classification of diabetes mellitus. Diabetes care 2013; 36 Suppl 1:S67-74.
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and
projections. Diabetes care 1998, 21(9):1414-1431.
Björntorp P. Neuroendocrine perturbations as a cause of insulin resistance. Diabetes/metabolism research and
reviews 1999; 15:427-441.
Wakabayashi I. Cross-sectional relationship between alcohol consumption and prevalence of metabolic
syndrome in Japanese men and women. Journal of atherosclerosis and thrombosis 2010; 17:695-704.
Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and
impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non- Communicable Diseases of Iran. Diabetes care 2008, 31(1):96-98.
Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in
Oman. Diabet Med 2002, 19 (11): 954-957.
Gokcel A, Ozsahin AK, Sezgin N, Karakose H, Ertorer ME, Akbaba M, et al. High prevalence of diabetes in
Adana, a southern province of Turkey. Diabetes care 2003, 26(11): 3031-3034.
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran
Lipid and Glucose Study. Diabetes Res Clin Pract 2003, 61(1):29-37.
Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance
between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007, 77(2):251-257.
Azadbakht L, Mirmiran P, Shiva N, Azizi F. General obesity and central adiposity in a representative sample of
Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res 2005, 75(4): 297-304.
Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central fat accumulation among
Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab 2005,
(1):3-8.
Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and
determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes care 1995,
(9): 1270-1273.
Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of
European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology
Study Group. Bmj 1998, 317(7155): 371-375.
Glumer C, Jorgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish
population: the Inter99 study. Diabetes care 2003, 26(8):2335-2340.
Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of
diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study
(CURES-17). Diabetologia 2006, 49(6):1175-1178.
Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, et al. The rising prevalence
of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes care
, 25(5):829-834.
Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes
and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination
Survey 1999-2002. Diabetes care 2006, 29(6):1263-1268.
Ramachandran A, Snehalatha C, Satyavani K, Vijay V. Impaired fasting glucose and impaired glucose tolerance
in urban population in India. Diabet Med 2003, 20(3):220-224.
Jaber LA, Brown MB, Hammad A, Nowak SN, Zhu Q, Ghafoor A, et al. Epidemiology of diabetes among Arab
Americans. Diabetes care 2003, 26(2):308-313.
Ozdemir L, Topcu S, Nadir I, Nur N, Arslan S, Sumer H. The prevalence of diabetes and impaired glucose
tolerance in Sivas, Central Anatolia, Turkey. Diabetes care 2005, 28(4):795-798.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. High prevalence of diabetes and
impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001, 44(9):1094-1101.
Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in
U.S. adults, 1997-2003.Am J Prev Med 2006, 30(5):371-377.
Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, et al.Determinants of serum HDL-C
level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutrition, metabolism, and
cardiovascular diseases: NMCD 2002; 12:80-89
Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum
lipid levels in twins. New England Journal of Medicine 1993; 328:1150-1156
Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, et al.Genome Scan for Quantitative Trait
Loci Linked to High-Density Lipoprotein Cholesterol The NHLBI Family Heart Study. Arteriosclerosis,
thrombosis, and vascular biology 2001; 21:1823-1828
Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab
Res Rev 2000, 16(4):230-236.
Hadaegh F, Zabetian A, Harati H, Azizi F. Waist/height ratio as a better predictor of type 2 diabetes compared
to body mass index in Tehranian adult men-a 3.6-year prospective study. Exp Clin Endocrinol Diabetes 2006,
(6):310-315.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
